News

Is Eli Lilly Stock a Buy? Here's What the Market Isn't Pricing in Yet.

Wall Street loves a dominant player, and Eli Lilly (NYSE: LLY) looks unstoppable with its obesity blockbusters printing money ...

Novo Nordisk’s Wegovy gets accelerated US approval for liver disease MASH

Wegovy is the first GLP-1 treatment approved for MASH. Read more at straitstimes.com. Read more at straitstimes.com.
Indy100 on MSN17h

Is Trump to blame for the UK’s 170% Mounjaro price surge?

The cost of Mounjaro, a popular weight-loss injection, is set to rise sharply in the UK – from £122 to £330 – a 170 per cent increase starting this September. The price hike, confirmed by US ...